A Randomized Controlled Trial of the Integrated Cancer Care Access Network on Cancer Treatment Completion and Quality of Life.
Francesca Gany, Irina Melnic, Yuelin Li...
https://pubmed.ncbi.nlm.nih.gov/40494401Actively Recruiting
Age: 21Years - 80Years
All Genders
ID01742143
A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-04-28
347
Participants Needed
11
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Memorial Sloan Kettering Cancer Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the Integrated Cancer Care Access Network (ICCAN) program to see how well it supports cancer patients in completing their treatment and improving their quality of life. This study compares the ICCAN program to the usual hospital services provided in New York City, such as meeting with a Social Worker or a Patient Navigator. The focus is on Black, Hispanic, and/or low socioeconomic status patients receiving treatment for triple-negative breast cancer (TNBC) and lung cancer in the New York metropolitan area. Participants in the ICCAN program receive written materials about social and economic resources, an initial needs assessment, and monthly follow-up with an ICCAN Access Facilitator to assist with ongoing needs. Both the ICCAN group and the usual care group receive the same written materials and treatment outcome surveys. The study includes a Phase I refinement and a Phase II randomized controlled trial comparing usual care to the ICCAN intervention. During the study, participants complete treatment outcomes surveys at intake, and at 3, 6, and 12 months. Researchers review medical charts at these time points and as needed. The main outcomes measured are treatment completion and adherence after one year, along with quality of life. The study also includes ongoing assessments of participant needs and assistance with social and economic challenges to support treatment adherence. The total participation duration is one year.
CONDITIONS
Brief Title
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Who Can Participate
Age: 21Years - 80Years
All Genders
Eligibility Criteria
You may qualify if you...
- Fluent in English, Spanish, or Mandarin
- Between 21 and 80 years old
- Cancer patients currently receiving chemotherapy started within the past month and/or radiation therapy started within the past week, or scheduled to begin chemotherapy and/or radiation therapy within the next 2 months
- Planning to remain in the area for at least 1 year
You will not qualify if you...
- Presence of untreated psychiatric disturbance or cognitive impairment that prevents completing assessments or giving informed consent
- Participation by patients or family members in MSK IHCD studies related to social determinants of health
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - Up to 1 year
Participants receive written materials on social and economic resources and services. Initial needs assessment and ongoing monthly follow-up with an ICCAN Access Facilitator address social and economic needs.
Monthly visits and additional as-needed visits
Long-term Monitoring
Duration - 1 year
Participants complete Treatment Outcomes Surveys and chart reviews at intake, 3 months, 6 months, and 1 year to assess treatment completion and quality of life.
4 survey visits and chart reviews at intake, 3 months, 6 months, and 1 year
Trial Site Locations
Total: 11 locations
1
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, United States, 07920
Actively Recruiting
2
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown, New Jersey, United States, 07748
Actively Recruiting
3
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, United States, 07645
Actively Recruiting
4
Lutheran Medical Center
Brooklyn, New York, United States, 11220
Active, Not Recruiting
5
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities)
Commack, New York, United States, 11725
Actively Recruiting
6
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, New York, United States, 10604
Actively Recruiting
7
City College of New York (Data Collection AND Data Analysis)
New York, New York, United States, 10031
Actively Recruiting
8
Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities)
New York, New York, United States, 10035
Actively Recruiting
9
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
10
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Rockville Centre, New York, United States, 11553
Actively Recruiting
11
Lincoln Hospital and Mental Health Center
The Bronx, New York, United States
Active, Not Recruiting
Loading map...
Research Team
F
Francesca Gany, MD, MS
J
Jennifer Leng, MD, MPH
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here